-
- News
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current IssueIPC APEX EXPO 2024 Pre-show
This month’s issue devotes its pages to a comprehensive preview of the IPC APEX EXPO 2024 event. Whether your role is technical or business, if you're new-to-the-industry or seasoned veteran, you'll find value throughout this program.
Boost Your Sales
Every part of your business can be evaluated as a process, including your sales funnel. Optimizing your selling process requires a coordinated effort between marketing and sales. In this issue, industry experts in marketing and sales offer their best advice on how to boost your sales efforts.
The Cost of Rework
In this issue, we investigate rework's current state of the art. What are the root causes and how are they resolved? What is the financial impact of rework, and is it possible to eliminate it entirely without sacrificing your yields?
- Articles
- Columns
Search Console
- Links
- Events
||| MENU - smt007 Magazine
OEM Contract Manufacturing to Grow $11 Billion by 2011
October 9, 2007 |Estimated reading time: 1 minute
The next few years are expected to be lucrative ones for OEMs (Original Equipment Manufacturers) and contract manufacturer companies processing raw materials for medical device companies--especially in niche areas and among OEMs that offer flexibility to move with market changes. The materials processing area of contract manufacturing for device manufacturing will grow from $13.9 billion globally to $25.41 billion by 2011, according to OEM Contract Manufacturing in Medical Devices, Volume I: Materials Processing, a new report by Kalorama Information.
The trend towards the incorporation of outsourced technologies will be particularly prevalent in product areas where biocompatibility is required for the fusion between biotechnology, chemistry, and medical device technologies. OEMs whose core competencies lie in only one of these areas will require expert input in the other areas that are complementary.
Future growth in the medical devices/drugs fusion industry is likely to come in orthopedics and implants as well as in the cardiovascular devices sector, where issues relating to biocompatibility, anti-microbial sterilization, device coatings, and drug release mean that specialist contract manufacturers are likely to be in increasing demand.
"The medical device industry today is similar to the electronics industry 20 years ago, when around 20% of the cost of manufacturing was outsourced," said Steven Heffner, publisher of Kalorama Information. "That number has now elevated to an estimated 90%. In the medical device industry across the mainstream nine market segments, the level of outsourcing of manufacturing costs is currently around 30%, so there is considerable room for growth and manufacturing efficiencies to be gained during the next five to ten years."
OEM Contract Manufacturing in Medical Devices is a three-volume series focusing on the manufacturers currently servicing global leading brand name manufacturers within the healthcare medical devices sectors. Future reports will define markets for electronic systems and finished medical device products. The report analyzes the market in nine therapeutic areas, leading competitors, and current issues and trends affecting the industry. It can be purchased from Kalorama Information by visiting: http://www.kaloramainformation.com/OEM-Contract-Manufacturing-1378138.
About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research on medical markets. For more information, contact Tom Ehart at 240-747-3014 or tehart@marketresearch.com, or visit www.KaloramaInformation.com.